TG Therapeutics
TGTX
TGTX
197 hedge funds and large institutions have $1.11B invested in TG Therapeutics in 2022 Q4 according to their latest regulatory filings, with 41 funds opening new positions, 63 increasing their positions, 57 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
9% more funds holding
Funds holding: 181 → 197 (+16)
4.75% less ownership
Funds ownership: 68.96% → 64.22% (-4.7%)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Holders
197
Holding in Top 10
–
Calls
$79.4M
Puts
$52.5M
Top Buyers
| 1 | +$26.4M | |
| 2 | +$19.3M | |
| 3 | +$17.8M | |
| 4 |
Alkeon Capital Management
New York
|
+$16.6M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$8.95M |
Top Sellers
| 1 | -$295M | |
| 2 | -$40M | |
| 3 | -$18.1M | |
| 4 |
DM
Deerfield Management
New York
|
-$15.9M |
| 5 |
State Street
Boston,
Massachusetts
|
-$15.8M |